Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	86,823	80,564	89,440	89,135	80,007	61,754
Revenue Growth	7.22%	-9.93%	0.34%	11.41%	29.56%	0.52%
Gross Profit Gross Profit Growth	37,027	33,437	40,666	37,570	35,645	24,441
Operating Income Operating Income Growth	5,835	7,386	15,222	13,991	13,656	7,982
Net Income Net Income Growth	6,419	7,531	14,301	13,641	12,157	6,679
Earnings Per Share EPS Growth	-	651.49	1237.13	1179.82	1092.89	594.11
EPS Growth	-	-47.34%	4.86%	7.95%	83.95%	-11.37%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	40,921	39,214	33,713	23,419	23,354	20,870
Total Debt Total Debt Growth	227.49	283.19	432.68	544.13	139.48	273.22
Net Cash (Debt) Net Cash Growth	40,694	38,931	33,281	22,875	23,214	20,597
Net Cash Growth	15.14%	16.98%	45.49%	-1.46%	12.71%	45.04%
Net Cash Per Share Net Cash Per Share Growth	-	3367.83	2879.07	1978.43	2086.88	1832.18

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	10,895	11,589	22,689	15,154	13,688	11,163
Capital Expenditures CapEx Growth	-2,897	-3,145	-10,362	-13,604	-10,351	-3,343
Free Cash Flow Free Cash Flow Growth	7,997	8,444	12,327	1,551	3,336	7,820
Free Cash Flow Growth	5.12%	-31.50%	694.85%	-53.52%	-57.34%	245.93%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	42.65%	41.50%	45.47%	42.15%	44.55%	39.58%
Operating Margin	6.72%	9.17%	17.02%	15.70%	17.07%	12.93%
Pretax Margin	8.10%	10.67%	18.49%	16.78%	18.30%	13.51%
Profit Margin	7.39%	9.35%	15.99%	15.30%	15.20%	10.81%
FCF Margin	9.21%	10.48%	13.78%	1.74%	4.17%	12.66%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	10.71	9.17	5.12	6.43	7.97	19.21
P/FCF Ratio	8.59	8.18	5.93	56.56	29.03	16.41
PS Ratio	0.79	0.86	0.82	0.98	1.21	2.08

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error